In both acute myeloid leukemia (AML) and synovial sarcoma (SS), targeting BRD9 disrupts oncogenic transcriptional programs, including MYC, leading to reduced proliferation and induction of apoptosis.

View post: I’m a Physical Therapist. This Is Why Stretching Your Tight Hamstrings Might Actually Be Making the Problem Worse View post: We’re Selling 7 Blanton’s Straight From the Barrel for a ...

Men’s Journal aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. For decades, the classic Maglite dominated the category. But ...

We may receive a commission on purchases made from links. Whether you spend your days laboring on a work site or in a garage, or count yourself among the millions of home improvement DIYers in the ...

We may receive a commission on purchases made from links. If you want to carry an easily concealable high-powered flashlight like those used by agents of the Federal Bureau of Investigation (FBI), ...

A 3D virtual model of the PKMYT1–PROTAC–CRBN ternary complex depicting how Insilico Medicine’s bifunctional proteolysis-targeting chimera (PROTAC) D16-M1P2 (shown in yellow) inhibits ...

AI Designs a Novel PROTAC from Scratch: Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its ...

Harbor Freight Tools was hit with a trademark and patent infringement lawsuit on June 26 in Delaware District Court over allegations it copied Streamlight's distinctive 'Ring Mark' design for ...

Streamlight has released the Sledge, a rechargeable flood headlamp designed for professional and outdoor use. The headlamp delivers 600 lumens on high with a run time of more than four hours, 300 ...

Reducing the time and expense of engineering PROTAC degraders remains a significant challenge in the pharmaceutical industry. A PROTAC is composed of an E3 ligase ligand (E3-L), a protein of interest ...

ARV-102 is an oral, brain-penetrant investigational PROTAC designed to degrade LRRK2, which is a large, multidomain scaffolding kinase. Increased activity, scaffolding, and expression of LRRK2 have ...